share_log

【BT财报瞬析】东星医疗2023三季报:资产负债率下降,现金流量净额增长显著

[BT Financial Report Instantaneous Analysis] Dongxing Medical's 2023 Quarterly Report: Balance ratio declined, net cash flow increased significantly

businesstimes cn ·  Oct 30, 2023 05:23

Announcement time of this financial report: 2023-10-24 18:26:56

East Star Medical (stock code: 301290) is a company specializing in the research, development, production and sales of surgical medical devices. The company's main products include stapler and its components, surgical equipment and medical device products sold by agents.

In terms of assets and liabilities, at the end of the third quarter of 2023, East Star Medical's total assets were 2.368 billion yuan, down slightly from 2.384 billion yuan at the end of last year. The total liability was 139 million yuan, a decrease of 22.78% compared with 180 million yuan at the end of the previous year, and the asset-liability ratio decreased from 7.55% at the end of last year to 5.87% at the end of this reporting period, showing the effect of the company's debt management. The company's net worth was 2.229 billion yuan, up from 2.204 billion yuan at the end of last year.

In terms of profit, the company's operating income in the third quarter of 2023 was 311 million yuan, slightly lower than the 318 million yuan in the same period last year. The operating cost was 162 million yuan, up from 143 million yuan in the same period last year, which may be one of the reasons for the decline in operating revenue. In spite of this, the company's net profit was 73.6023 million yuan, down from 77.5193 million yuan in the same period last year, but remained at a high level. The gross profit margin was 48%, down from 54.97% in the same period last year, and the net profit margin was 23.66%, down slightly from 24.4% in the same period last year.

In terms of cash flow, the net cash flow generated by Dongxing Medical's operating activities in the third quarter of 2023 was 98.3447 million yuan, an increase of 22.81% over 80.0796 million yuan in the same period last year, indicating that the cash inflow capacity of the company's operating activities has improved.

Generally speaking, although the operating income and net profit of East Star Medical decreased in the third quarter of 2023 compared with the same period last year, the company's asset-liability ratio decreased and its net cash flow increased significantly, indicating that the company's overall operating condition was stable. For investors, they can pay attention to the future development trend of the company and the dynamics of the industry in order to make more informed investment decisions.

This article only represents the judgment made by the analyst himself or the analyst on the basis of AI analysis, and can not be used as any investment index, nor does it constitute any investment advice. The original intention of this paper is to help investors analyze and judge the capital market data in the most intuitive and fast way and from the most professional perspective.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment